Mark Schallenberger
Fortune : 306 379 $ au 31/05/2026
Fortune : 306 379 $ au 31/05/2026
Mr. Mark A. Schallenberger is a Chief Operating Officer at Xtant Medical Holdings, Inc. Mr. Schallenberger was previously employed as a Chief Operations Officer by Surgenex LLC and a Senior Director-Marketing & Product Development by DCI Donor Services Tissue Bank.
He received his undergraduate degree from The University of Montana and a graduate degree from The Scripps Research Institute.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/02/2026 | 663 157 ( 0,47% ) | 306 379 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| XTANT MEDICAL HOLDINGS, INC. | Directeur des opérations | 16/01/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
Surgenex LLC
Surgenex LLC Miscellaneous Commercial ServicesCommercial Services Develops and commercializes human cellular & tissue-based products | Directeur des opérations | 01/01/2023 |
DCI Donor Services Tissue Bank | Corporate Officer/Principal | 01/06/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Montana
The University of Montana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures and commercializes surgical products | Health Technology |
Surgenex LLC
Surgenex LLC Miscellaneous Commercial ServicesCommercial Services Develops and commercializes human cellular & tissue-based products | Commercial Services |
DCI Donor Services Tissue Bank |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national